Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis

American Journal of Rhinology and Allergy

Volumn 26, Issue 1, 2012, Pages

  Wang, Ling Feng ^a,d   Chien, Chen Yu ^c,d   Chiang, Feng Yu ^a,d   Chai, Chee Yin ^b   Tai, Chih Feng ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CHRONIC DISEASE; CHRONIC RHINOSINUSITIS WITH NASAL POLYPS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPIC SINUS SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NOSE POLYP; PROTEIN EXPRESSION; RECURRENT DISEASE; RHINOSINUSITIS;

CHRONIC DISEASE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, MUCOSAL; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NASAL MUCOSA; NASAL POLYPS; PARANASAL SINUSES; RECURRENCE; RHINITIS; SEVERITY OF ILLNESS INDEX; SINUSITIS; UP-REGULATION;

EID: 84863255305     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3724     Document Type: Article

References (38)

1. Polzehl D, Moeller P, Riechelmann H, et al. Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy 61: 1275-1279, 2006. (Pubitemid 44465586)
2. Bousquet J, Chanez P, Lacoste JY, et al. Asthma: A disease remodeling the airways. Allergy 47:3-11, 1992.
3. Shaida A, Kenyon G, Devalia J, et al. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 108:791-796, 2001. (Pubitemid 33096212)
4. Shapiro SD, and Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 20:1100-1102, 1999.
5. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 148:1345-1350, 1996.
6. Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267:21712-21719, 1992.
7. Welgus HG, Campbell EJ, Cury JD, et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest 86:1496-1502, 1990. (Pubitemid 20372596)
8. Hibbs MS, Hasty KA, Seyer JM, et al. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260:2493-2500, 1985. (Pubitemid 15104858)
9. Yao PM, Buhler JM, d'Ortho MP, et al. Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem 271:15580-15589, 1996. (Pubitemid 26226716)
10. Wert SE, Yoshida M, LeVine AM, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 97:5972-5977, 2000. (Pubitemid 30367508)
11. Hoshino M, Nakamura Y, Sim J, et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 102:783-788, 1998. (Pubitemid 28543528)
12. Belleguic C, Corbel M, Germain N, et al. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 32:217-223, 2002. (Pubitemid 34429599)
13. Chen Y, Chen P, Hanaoka M, et al. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 13:1014-1021, 2008.
14. Cundall M, Sun Y, Miranda C, et al. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 112:1064-1071, 2003. (Pubitemid 37549996)
15. Wenzel SE, Balzar S, Cundall M, et al. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: Association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 111:1345-1352, 2003. (Pubitemid 36683691)
16. Lee YM, Kim SS, Kim HA, et al. Eosinophil inflammation of nasal polyp tissue: Relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 18:97-102, 2003.
17. Bhandari A, Takeuchi K, Suzuki S, et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol 124: 1165-1170, 2004. (Pubitemid 40051567)
18. Lechapt-Zalcman E, Coste A, d'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193:233-241, 2001. (Pubitemid 32120085)
19. Watelet JB, Bachert C, Claeys C, et al. Matrix metalloproteinases MMP-7, MMP-9, and their tissue inhibitor TIMP-1: Expression in chronic sinusitis vs nasal polyposis. Allergy 59:54-60, 2004. (Pubitemid 38167952)
20. Wang JH, Kwon HJ, and Jang YJ. Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy 24:422-427, 2010.
21. Bugdayci G, Kaymakci M, and Bukan N. Matrix metalloproteinase-9 (MMP-9) in allergic nasal polyps. Acta Histochem 112:92-95, 2010.
22. Watelet JB, Demetter P, Claeys C, et al. Wound healing after paranasal sinus surgery: Neutrophilic inflammation influences the outcome. Histopathology 48:174-181, 2006.
23. Watelet JB, Demetter P, Claeys C, et al. Neutrophil-derived metalloproteinase- 9 predicts healing quality after sinus surgery. Laryngoscope 115:56-61, 2005. (Pubitemid 40096528)
24. Watelet JB, Claeys C, Van Cauwenberge P, et al. Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Repair Regen 12:412-418, 2004. (Pubitemid 39007041)
25. Fokkens W, Lund V, and Mullol J. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 45:97-101, 2007.
26. Lund VJ, and Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 117:S35-S40, 1997. (Pubitemid 27435427)
27. Lund VJ, and Mackay IS. Staging in rhinosinusitis. Rhinology 31:183-184, 1993.
28. Garcia-Marcos L, Sanchez-Solis M, Martinez-Torres AE, et al. Phadiatop compared to skin-prick test as a tool for diagnosing atopy in epidemiological studies in schoolchildren. Pediatr Allergy Immunol 18:240-244, 2007. (Pubitemid 46587706)
29. Vidal C, Gude F, Boquete O, et al. Evaluation of the Phadiatop test in the diagnosis of allergic sensitization in a general adult population. J Investig Allergol Clin Immunol 15:124-130, 2005. (Pubitemid 41020174)
30. Buisson AC, Zahm JM, Polette M, et al. Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium. J Cell Physiol 166:413-426, 1996. (Pubitemid 26042419)
31. Tournier JM, Polette M, Hinnrasky J, et al. Expression of gelatinase A, a mediator of extracellular matrix remodeling, by tracheal gland serous cells in culture and in vivo. J Biol Chem 269:25454-25464, 1994. (Pubitemid 24336233)
32. Lelongt B, Trugnan G, Murphy G, et al. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136:1363-1373, 1997. (Pubitemid 27421921)
33. Shimizu T, Kanai K, Asano K, et al. Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro. Mediators Inflamm 2005:150-159, 2005. (Pubitemid 41381523)
34. Mattos W, Lim S, Russell R, et al. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 122:1543-1552, 2002. (Pubitemid 35366062)
35. Boulay ME, Prince P, Deschesnes F, et al. Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response. Respiration 71:216-224, 2004. (Pubitemid 38608338)
36. Baraldo S, Bazzan E, Zanin ME, et al. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest 132:1733-1740, 2007.
37. Dursun E, Korkmaz H, Eryilmaz A, et al. Clinical predictors of long-term success after endoscopic sinus surgery. Otolaryngol Head Neck Surg 129:526-531, 2003. (Pubitemid 37377583)
38. Li Y, Zhang GH, Liu X, et al. Clinical prognostic factors of chronic rhinosinusitis after endoscopic sinus surgery. ORL J Otorhinolaryngol Relat Spec 70:113-117, 2008. (Pubitemid 351535830)